Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 297

1.

SLIM trims STATs: ubiquitin E3 ligases provide insights for specificity in the regulation of cytokine signaling.

Ungureanu D, Silvennoinen O.

Sci STKE. 2005 Oct 4;2005(304):pe49. Review.

PMID:
16204702
2.

SLIM is a nuclear ubiquitin E3 ligase that negatively regulates STAT signaling.

Tanaka T, Soriano MA, Grusby MJ.

Immunity. 2005 Jun;22(6):729-36.

3.

Negative regulators of cytokine signaling.

Kile BT, Nicola NA, Alexander WS.

Int J Hematol. 2001 Apr;73(3):292-8. Review.

PMID:
11345194
4.
5.

Jak-STAT signaling pathways in cells of the immune system.

Ivashkiv LB.

Rev Immunogenet. 2000;2(2):220-30. Review.

PMID:
11258419
6.

[Negative regulation of the JAK/STAT: pathway implication in tumorigenesis].

Espert L, Dusanter-Fourt I, Chelbi-Alix MK.

Bull Cancer. 2005 Oct;92(10):845-57. French.

PMID:
16266868
7.

Controlling cytokine signaling by constitutive inhibitors.

Rakesh K, Agrawal DK.

Biochem Pharmacol. 2005 Sep 1;70(5):649-57. Review.

PMID:
15936728
8.

Regulation of Sprouty2 stability by mammalian Seven-in-Absentia homolog 2.

Nadeau RJ, Toher JL, Yang X, Kovalenko D, Friesel R.

J Cell Biochem. 2007 Jan 1;100(1):151-60.

PMID:
16888801
9.

Suppressors of cytokine signalling: SOCS.

Larsen L, Röpke C.

APMIS. 2002 Dec;110(12):833-44. Review.

PMID:
12645661
10.

The E3 ubiquitin ligase HOIL-1 induces the polyubiquitination and degradation of SOCS6 associated proteins.

Bayle J, Lopez S, Iwaï K, Dubreuil P, De Sepulveda P.

FEBS Lett. 2006 May 15;580(11):2609-14. Epub 2006 Apr 21.

11.

Regulation of TGF-beta family signaling by E3 ubiquitin ligases.

Inoue Y, Imamura T.

Cancer Sci. 2008 Nov;99(11):2107-12. doi: 10.1111/j.1349-7006.2008.00925.x. Epub 2008 Sep 18. Review.

12.

New insights into the role of the ubiquitin-proteasome pathway in the regulation of apoptosis.

Liu CH, Goldberg AL, Qiu XB.

Chang Gung Med J. 2007 Nov-Dec;30(6):469-79. Review.

13.

E3 ubiquitin ligases as regulators of membrane protein trafficking and degradation.

d'Azzo A, Bongiovanni A, Nastasi T.

Traffic. 2005 Jun;6(6):429-41. Review.

PMID:
15882441
14.

A crosstalk between hSiah2 and Pias E3-ligases modulates Pias-dependent activation.

Depaux A, Regnier-Ricard F, Germani A, Varin-Blank N.

Oncogene. 2007 Oct 11;26(46):6665-76. Epub 2007 May 28.

PMID:
17533377
15.

AIP4 restricts transforming growth factor-beta signaling through a ubiquitination-independent mechanism.

Lallemand F, Seo SR, Ferrand N, Pessah M, L'Hoste S, Rawadi G, Roman-Roman S, Camonis J, Atfi A.

J Biol Chem. 2005 Jul 29;280(30):27645-53. Epub 2005 Jun 8.

16.

Regulation of immune responses by E3 ubiquitin-protein ligases.

Fang N, Fang D, Wang HY, Altman A, Liu YC.

Curr Dir Autoimmun. 2002;5:161-75. Review. No abstract available.

PMID:
11826757
17.

Gfi1 ubiquitination and proteasomal degradation is inhibited by the ubiquitin ligase Triad1.

Marteijn JA, van der Meer LT, van Emst L, van Reijmersdal S, Wissink W, de Witte T, Jansen JH, Van der Reijden BA.

Blood. 2007 Nov 1;110(9):3128-35. Epub 2007 Jul 23.

18.

JAK/STAT signal transduction: regulators and implication in hematological malignancies.

Valentino L, Pierre J.

Biochem Pharmacol. 2006 Mar 14;71(6):713-21. Epub 2006 Jan 19. Review.

PMID:
16426581
19.

Structure, function, and regulation of STAT proteins.

Lim CP, Cao X.

Mol Biosyst. 2006 Nov;2(11):536-50. Epub 2006 Sep 26. Review.

PMID:
17216035
20.

The JAK-STAT pathway: a therapeutic target in hematological malignancies.

Ferrajoli A, Faderl S, Ravandi F, Estrov Z.

Curr Cancer Drug Targets. 2006 Dec;6(8):671-9. Review.

PMID:
17168672
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk